Literature DB >> 4325104

Vitamin D metabolism: the role of kidney tissue.

R Gray, I Boyle, H F DeLuca.   

Abstract

The appearance of a polar metabolite of 25-hydroxychotecalciferol has been studied in the intestinal mucosas of nephrectomized rats and rats which have been made uremic by ureter ligation. In confirmation of previous work by Fraser and Kodicek, it was found that nephrectomy prevents the appearance of this metabolite in the intestine. On the other hand, equivalent amounts of the metabolite were found in uremic rats and in sham-operated controls, showing that the production of this metabolite is independent of the uremic state of the animals. In addition, it was shown that the metabolite produced in vitro by kidney homogenates is identical to that found in vivo in the intestine.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4325104     DOI: 10.1126/science.172.3989.1232

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  52 in total

1.  CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin.

Authors:  Janeen L Vanhooke; Jean M Prahl; Christine Kimmel-Jehan; Monica Mendelsohn; Eric W Danielson; Kevin D Healy; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

2.  25-Hydroxyvitamin D3 regulation.

Authors:  M B Clark; J T Potts
Journal:  Calcif Tissue Res       Date:  1977-05

3.  The role of phosphate in the action of vitamin D on the intestine.

Authors:  S J Birge; R Miller
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

4.  Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men.

Authors:  A A Portale; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  Metabolism of 1,25-dihydroxycholecalciferol in the rat.

Authors:  C A Frolik; H F DeLuca
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

6.  Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.

Authors:  R G Wong; A W Norman; C R Reddy; J W Coburn
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

7.  Acute suppression of bone turnover with calcium infusion in persons with spinal cord injury.

Authors:  William A Bauman; Run-Lin Zhang; Nancy Morrison; Ann M Spungen
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

8.  Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination.

Authors:  T D Shultz; J Fox; H Heath; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.

Authors:  Jyothsna Gattineni; Carlton Bates; Katherine Twombley; Vangipuram Dwarakanath; Michael L Robinson; Regina Goetz; Moosa Mohammadi; Michel Baum
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-10

10.  Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog.

Authors:  J M Canterbury; S Lerman; A J Claflin; H Henry; A Norman; E Reiss
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.